Carbohydrate-binding agents: a potential future cornerstone for the chemotherapy of enveloped viruses? (Q36758492)

16 August 2017

1 reference

title

Carbohydrate-binding agents: a potential future cornerstone for the chemotherapy of enveloped viruses? (English)

1 reference

16 August 2017

1 reference

Jan Balzarini

1

1 reference

16 August 2017

1 January 2007

1 reference

Antiviral Chemistry & Chemotherapy

16 August 2017

1 reference

16 August 2017

18

1 reference

16 August 2017

1

1 reference

16 August 2017

1-11

1 reference

Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin

16 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Large-molecular-weight carbohydrate-binding agents as HIV entry inhibitors targeting glycoprotein gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Inhibition of HIV entry by carbohydrate-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Intravaginal and intrarectal microbicides to prevent HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Alpha-(1-3)- and alpha-(1-6)-D-mannose-specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

The mannose-specific plant lectins from Cymbidium hybrid and Epipactis helleborine and the (N-acetylglucosamine)n-specific plant lectin from Urtica dioica are potent and selective inhibitors of human immunodeficiency virus and cytomegalovirus replic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Profile of resistance of human immunodeficiency virus to mannose-specific plant lectins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Marked depletion of glycosylation sites in HIV-1 gp120 under selection pressure by the mannose-specific plant lectins of Hippeastrum hybrid and Galanthus nivalis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Carbohydrate-binding Agents Cause Deletions of Highly Conserved Glycosylation Sites in HIV GP120

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Mutational pathways, resistance profile, and side effects of cyanovirin relative to human immunodeficiency virus type 1 strains with N-glycan deletions in their gp120 envelopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Pradimicin A, a carbohydrate-binding nonpeptidic lead compound for treatment of infections with viruses with highly glycosylated envelopes, such as human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Carbohydrate-binding agents efficiently prevent dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)-directed HIV-1 transmission to T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Solution structure of cyanovirin-N, a potent HIV-inactivating protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Proteins that bind high-mannose sugars of the HIV envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

A vaccine for HIV type 1: the antibody perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Antibody domain exchange is an immunological solution to carbohydrate cluster recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

A general model for the surface glycoproteins of HIV and other retroviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

The microbicide cyanovirin-N expressed on the surface of commensal bacterium Streptococcus gordonii captures HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Pradimicin resistance of yeast is caused by a mutation of the putative N-glycosylation sites of osmosensor protein Sln1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Mannose-binding quinone glycoside, MBQ: potential utility and action mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Mannose binding lectin (MBL) and HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Mannose-binding lectin: do we need it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Mass spectrometric characterization of proteins from the SARS virus: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type 1 glycoprotein 120 by N-linked oligosaccharides in the V1 region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Folding of hepatitis C virus E1 glycoprotein in a cell-free system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Carbohydrate structures of the human-immunodeficiency-virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese-hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Structural characterization by chromatographic profiling of the oligosaccharides of human immunodeficiency virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Host cell glycosylation of viral glycoproteins--a battlefield for host defence and viral resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

A role for carbohydrates in immune evasion in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Glycosylation: heterogeneity and the 3D structure of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Glycosylation and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Pradimicin A inhibition of human immunodeficiency virus: attenuation by mannan

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Anti-human immunodeficiency virus (HIV) agents are also potent and selective inhibitors of feline immunodeficiency virus (FIV)-induced cytopathic effect: development of a new method for screening of anti-FIV substances in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Antigenic structure of the haemagglutinin of human influenza A/H2N2 virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Effect of addition of new oligosaccharide chains to the globular head of influenza A/H2N2 virus haemagglutinin on the intracellular transport and biological activities of the molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Role of overlapping glycosylation sequons in antigenic properties, intracellular transport and biological activities of influenza A/H2N2 virus haemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Sugar-binding proteins potently inhibit dendritic cell human immunodeficiency virus type 1 (HIV-1) infection and dendritic-cell-directed HIV-1 transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Functional hepatitis C virus envelope glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Pradimicins: a novel class of broad-spectrum antifungal compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Antibody neutralization and escape by HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

The C-type lectin superfamily in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

CD81 is required for hepatitis C virus glycoprotein-mediated viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800101

Pradimicin, a novel class of potent antifungal antibiotics

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.41.1701

Identifiers

DOI

10.1177/095632020701800101

1 reference

16 August 2017

1 reference

PubMed ID

17354647